Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:07 am Purchase | 2026-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | T. Rowe Price Associates, Inc. | 5,355,011 5.100% | 410,254 (+8.30%) | Filing History |
| 2026-05-15 07:34 am Sale | 2026-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 8,157,204 7.800% | -224,787 (-2.68%) | Filing History |
| 2026-05-15 07:08 am Purchase | 2026-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 6,395,922 6.110% | 1,356,445 (+26.92%) | Filing History |
| 2026-04-29 5:37 pm Purchase | 2026-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | VANGUARD CAPITAL MANAGEMENT LLC | 5,440,646 5.190% | 5,440,646 (New Position) | Filing History |
| 2026-03-26 5:40 pm Sale | 2026-03-13 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | VANGUARD GROUP INC | 0 0.000% | -9,311,600 (Position Closed) | Filing History |
| 2026-02-05 2:45 pm Purchase | 2025-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Farallon Capital Partners, L.P. | 8,024,098 8.500% | 2,399,000 (+42.65%) | Filing History |
| 2025-11-12 09:33 am Purchase | 2025-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 8,381,991 8.900% | 2,574,683 (+44.34%) | Filing History |
| 2025-09-08 5:36 pm Purchase | 2025-08-29 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Farallon Capital Partners, L.P. | 5,625,098 6.000% | 5,625,098 (New Position) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 5,807,308 6.200% | -1,143,259 (-16.45%) | Filing History |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 13,957,269 15.000% | 4,325,631 (+44.91%) | Filing History |
| 2025-04-07 11:52 am Purchase | 2025-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | VANGUARD GROUP INC | 9,311,600 10.000% | 222,209 (+2.44%) | Filing History |
| 2025-02-10 10:25 am Purchase | 2024-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 6,950,567 7.500% | 2,490,876 (+55.85%) | Filing History |
| 2025-02-07 10:23 am Purchase | 2025-01-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 9,631,638 10.400% | 727,552 (+8.17%) | Filing History |
| 2025-02-07 10:06 am Purchase | 2024-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 8,904,086 9.600% | 4,860,221 (+120.19%) | Filing History |
| 2025-01-30 9:33 pm Purchase | 2024-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | VANGUARD GROUP INC | 9,089,391 9.800% | 2,801,736 (+44.56%) | Filing History |
| 2024-11-14 7:55 pm Sale | 2024-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Point72 Asset Management, L.P. | 2,300,643 2.900% | -1,116,257 (-32.67%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | EcoR1 Capital LLC | 4,288,120 4.800% | 132,745 (+3.19%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | T. Rowe Price Associates, Inc. | 4,944,757 6.200% | 4,944,757 (New Position) | Filing History |
| 2024-11-12 2:26 pm Unchanged | 2024-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | VANGUARD GROUP INC | 6,287,655 7.850% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 4,459,691 5.570% | 1,214,586 (+37.43%) | Filing History |